Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2014 (2014), Article ID 721505, 7 pages
http://dx.doi.org/10.1155/2014/721505
Research Article

Daily Intake of Probiotics with High IFN-γ/IL-10 Ratio Increases the Cytotoxicity of Human Natural Killer Cells: A Personalized Probiotic Approach

Department of Research and Development, Bio Ray Biotech Inc., 3F., No. 466, Bo’ai 1st Road, Gushan District, Kaohsiung City 80466, Taiwan

Received 17 July 2014; Revised 18 November 2014; Accepted 20 November 2014; Published 11 December 2014

Academic Editor: Mario Clerici

Copyright © 2014 Yu-Hsuan Ho et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Z. Iqbal, M. I. Qadir, T. Hussain, K. H. Janbaz, Y. H. Khan, and B. Ahmad, “Review: probiotics and their beneficial effects against various diseases,” Pakistan Journal of Pharmaceutical Sciences, vol. 27, no. 2, pp. 405–415, 2014. View at Google Scholar · View at Scopus
  2. E. S. L. Chong, “A potential role of probiotics in colorectal cancer prevention: review of possible mechanisms of action,” World Journal of Microbiology and Biotechnology, vol. 30, no. 2, pp. 351–374, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Ebel, G. Lemetais, L. Beney et al., “Impact of probiotics on risk factors for cardiovascular diseases. A review,” Critical Reviews in Food Science and Nutrition, vol. 54, no. 2, pp. 175–189, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Gou, Z. Yang, T. Liu, H. Wu, and C. Wang, “Use of probiotics in the treatment of severe acute pancreatitis: a systematic review and meta-analysis of randomized controlled trials,” Critical Care, vol. 18, no. 2, article R57, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Uccello, G. Malaguarnera, F. Basile et al., “Potential role of probiotics on colorectal cancer prevention,” BMC Surgery, vol. 12, supplement 1, article S35, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Kahouli, C. Tomaro-Duchesneau, and S. Prakash, “Probiotics in colorectal cancer (CRC) with emphasis on mechanisms of action and current perspectives,” Journal of Medical Microbiology, vol. 62, part 8, pp. 1107–1123, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Končarević, C. Lößner, K. Kuhn, T. Prinz, I. Pike, and H.-D. Zucht, “In-depth profiling of the peripheral blood mononuclear cells proteome for clinical blood proteomics,” International Journal of Proteomics, vol. 2014, Article ID 129259, 9 pages, 2014. View at Publisher · View at Google Scholar
  8. E. Shereck, P. Satwani, E. Morris, and M. S. Cairo, “Human natural killer cells in health and disease,” Pediatric Blood and Cancer, vol. 49, no. 5, pp. 615–623, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. I. Langers, V. M. Renoux, M. Thiry, P. Delvenne, and N. Jacobs, “Natural killer cells: role in local tumor growth and metastasis,” Biologics: Targets and Therapy, vol. 6, pp. 73–82, 2012. View at Google Scholar · View at Scopus
  10. E. A. Ojo-Amaize, E. J. Conley, and J. B. Peter, “Decreased natural killer cell activity is associated with severity of chronic fatigue immune dysfunction syndrome,” Clinical Infectious Diseases, vol. 18, no. 1, pp. S157–S159, 1994. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Bruunsgaard, A. N. Pedersen, M. Schroll, P. Skinhoj, and B. K. Pedersen, “Decreased natural killer cell activity is associated with atherosclerosis in elderly humans,” Experimental Gerontology, vol. 37, no. 1, pp. 127–136, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Froom, E. Aghai, A. Kinarty, and N. Lahat, “Decreased natural killer (NK) activity in patients with myeloproliferative disorders,” Cancer, vol. 64, no. 5, pp. 1038–1040, 1989. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Denys, S. Fluitman, A. Kavelaars, C. Heijnen, and H. Westenberg, “Decreased TNF-α and NK activity in obsessive-compulsive disorder,” Psychoneuroendocrinology, vol. 29, no. 7, pp. 945–952, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. W.-H. Sha, X.-H. Zeng, and L. Min, “The correlation between NK cell and liver function in patients with primary hepatocellular carcinoma,” Gut and Liver, vol. 8, no. 3, pp. 298–305, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Liu, S. Lu, X. Wang et al., “Perturbation of NK cell peripheral homeostasis accelerates prostate carcinoma metastasis,” Journal of Clinical Investigation, vol. 123, no. 10, pp. 4410–4422, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Furue, K. Matsuo, H. Kumimoto et al., “Decreased risk of colorectal cancer with the high natural killer cell activity NKG2D genotype in Japanese,” Carcinogenesis, vol. 29, no. 2, pp. 316–320, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Takeda and K. Okumura, “Effects of a fermented milk drink containing Lactobacillus casei strain Shirota on the human NK-cell activity,” The Journal of Nutrition, vol. 137, no. 3, pp. 791S–793S, 2007. View at Google Scholar · View at Scopus
  18. M. Reale, P. Boscolo, V. Bellante et al., “Daily intake of Lactobacillus casei Shirota increases natural killer cell activity in smokers,” British Journal of Nutrition, vol. 108, no. 2, pp. 308–314, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Reale, P. Boscolo, V. Bellante et al., “Daily intake of Lactobacillus casei Shirota increases natural killer cell activity in smokers,” British Journal of Nutrition, vol. 108, no. 2, pp. 308–314, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. D. J. Costa, P. Marteau, M. Amouyal et al., “Efficacy and safety of the probiotic Lactobacillus paracasei LP-33 in allergic rhinitis: a double-blind, randomized, placebo-controlled trial (GA2LEN Study),” European Journal of Clinical Nutrition, vol. 68, no. 5, pp. 602–607, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Ishida, F. Nakamura, H. Kanzato et al., “Clinical effects of Lactobacillus acidophilus strain L-92 on perennial allergic rhinitis: a double-blind, placebo-controlled study,” Journal of Dairy Science, vol. 88, no. 2, pp. 527–533, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. L. K. Teixeira, B. P. F. Fonseca, B. A. Barboza, and J. P. B. Viola, “The role of interferon-γ on immune and allergic responses,” Memorias do Instituto Oswaldo Cruz, vol. 100, no. 1, pp. 137–144, 2005. View at Google Scholar · View at Scopus
  23. T. Levkovich, T. Poutahidis, C. Smillie et al., “Probiotic bacteria induce a “glow of health”,” PLoS ONE, vol. 8, no. 1, Article ID e53867, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. K. C. Anukam, K. Hayes, K. Summers, and G. Reid, “Probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 may help downregulate TNF-alpha, IL-6, IL-8, IL-10 and IL-12 (p70) in the neurogenic bladder of spinal cord injured patient with urinary tract infections: a two-case study,” Advances in Urology, vol. 2009, Article ID 680363, 5 pages, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Cheon, K. W. Lee, K. E. Kim et al., “Heat-killed Lactobacillus acidophilus La205 enhances NK cell cytotoxicity through increased granule exocytosis,” Immunology Letters, vol. 136, no. 2, pp. 171–176, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Itoh, T. Sashihara, A. Hosono, S. Kaminogawa, and M. Uchida, “Lactobacillus gasseri OLL2809 inhibits development of ectopic endometrial cell in peritoneal cavity via activation of NK cells in a murine endometriosis model,” Cytotechnology, vol. 63, no. 2, pp. 205–210, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Ménard, J.-Y. Blay, C. Borg et al., “Natural killer cell IFN-γ levels predict long-term survival with imatinib mesylate therapy in gastrointestinal stromal tumor-bearing patients,” Cancer Research, vol. 69, no. 8, pp. 3563–3569, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Konjevic, S. Radenkovic, T. Srdic, V. Jurisic, L. Stamatovic, and M. Milovic, “Association of decreased NK cell activity and IFNγ expression with pSTAT dysregulation in breast cancer patients,” Journal of B.U.ON., vol. 16, no. 2, pp. 219–226, 2011. View at Google Scholar · View at Scopus
  29. Y. Hayakawa, K. Takeda, H. Yagita et al., “IFN-γ-mediated inhibition of tumor angiogenesis by natural killer T-cell ligand, α-galactosylceramide,” Blood, vol. 100, no. 5, pp. 1728–1733, 2002. View at Google Scholar · View at Scopus
  30. E. Vivier and S. Ugolini, “Regulatory natural killer cells: new players in the IL-10 anti-inflammatory response,” Cell Host and Microbe, vol. 6, no. 6, pp. 493–495, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. G. Perona-Wright, K. Mohrs, F. M. Szaba et al., “Systemic but not local infections elicit immunosuppressive IL-10 production by natural killer cells,” Cell Host and Microbe, vol. 6, no. 6, pp. 503–512, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. M. J. Scott, J. J. Hoth, M. Turina, D. R. Woods, and W. G. Cheadle, “Interleukin-10 suppresses natural killer cell but not natural killer T cell activation during bacterial infection,” Cytokine, vol. 33, no. 2, pp. 79–86, 2006. View at Publisher · View at Google Scholar · View at Scopus